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We agree with Skidmore and Mawson that the persistence of
serum IFN-x may predict the development of AIDS in individuals
exposed to HIV. Furthermore serum IFN-x is correlated with a
marked deficiency of leucocyte IFN-CI. production in patients with
AIDS or ARC3 The diminished capacity of endogenous IFN
production may be responsible for the AID S patients’ susceptibility
to opportunistic infections.
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IMMUNOBLOT TEST WITH RECOMBINANT HIV
ANTIGENS
SiR,&mdash;Confirmation of a positive anti-HIV screening test result is
usually done by western blot (WB). Virus grown in tissue culture is
disrupted and viral proteins are separated by gel electrophoresis and
transferred to nitrocellulose paper. Attachment of serum antibody
to the paper at characteristic sites indicates specific antibody against
viral proteins. However, the conventional WB has disadvantages:
(a) it is expensive and time-consuming to produce in tissue culture
the large amount of virus needed; (b) HIV cultivation can only be
done in special laboratories, (c) the concentration and relative
amount of viral proteins may vary considerably in different antigen
preparations; (d) the diagnostically most important envelope
protein gp41 migrates as a diffuse band; and (e) false-positive
reactions may occur.1-3 The modification described here does not
have these disadvantages.
We use three recombinant proteins encoded by pUC-vectors4
and produced in Escherichia coli-namely, proteins exhibiting
antigenic epitopes of p24 (molecular weight 33 kD) and gp41 (20
kD) and a fusion protein of both (47 kD). Without purification E coli
lysates were subjected to SD S-PAGE and proteins were transferred
to nitrocellulose paper strips with three lanes. Because crude
bacterial lysates were used the background reaction in the modified
WB is significant but testing of sera on three lanes differing only in
the presence of one virus-encoded protein ensures specificity:
non-specific reactions with bacterial lysates can be seen in all three
lanes, whereas strong HIV-1 specific reactions for anti-p24 and
anti-gp4l are found only once in each lane at a characteristic
position (figure).
All three recombinant proteins are expressed without bacterial
fusion proteins to avoid cross-reaction with antibody to bacterial
proteins. We chose p24 because antibody to this protein seems to
appear earliest after HIV infection, gp41 because antibody to this
protein is the most specific for HIV-1 infection, and the fusion
protein gp41/p24 to provide independent confirmation and an
opportunity for blot interpretation where the background staining
in the other two lanes was heavy.
We evaluated the test on sera chosen from among routine
diagnostic specimens and on United States-derived plasma pools.
46 sera were tested, with the following results:
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ConzentzonaZ WB Recombmant WB
15 positive 15 positive (anti-p24 and anti-
gp41)
16 ? positive (no anti-gp41) 
z 
8 positive (anti-gp4l, some also
anti-p24); 8 negative for
anti-gp41
15 negative 13 negative; 2 positive (anti-
gp41)
Thus in this panel of 46 sera all conventional WB positive samples
were confirmed; the modified WB resulted in no "? positive" results
and seemed to resolve all 16 ? positive sera on conventional WB; and
2 conventional WB results were false negatives (both coming from
Reactivity in recombinant blot test of 2 sera lacking anti-gp41 and
designated ? positive on conventional WB.
Bacterial lysates contained (A) recombinant p24, (B) recombinant fusion
protein gp41/p24, and (C) recombinant gp41. HIV-1 specific reactions
marked by arrows.
patients with AIDS). Among the 16 ? positive specimens 4 sera
from two persons with recent seroconversion were identified by
recombinant WB suggesting that HIV-1 infection can be diagnosed
earlier after seroconversion if the recombinant blot test rather than
WB is used.
17 plasma pools have been tested:
Date EIA* Conventzonal WB Recorralnnara Tf7&bgr;
Aug to Dec, 5+ve 1+ve; 3 ?+ve; tl -ve 4+ve (anti-gp4l,
1985 (n = 10) not anti-p24)
1986-87
(n = 7) 1 +ve 7 ?+vet 7 - ve (neither
anti-gp41 nor
anti-p24)
*Recombinant enzyme immunoassay (Abbott).
tPosinve had reactivity to p24, p31, gp41, p51, p55, and p66. ? positives had
reactivity to p66, to p31 and to p5 and to p5 1.
T? positives had reactivity to p55 (5 samples), to p51 (1B and to p24 and p55 (1)
The results suggest that pooled plasma frequently exhibits
non-specific reactivity to p55 or p51. However, the positive results
for anti-gp41 found in recombinant blot tests in pools from 1985 are
probably specific.
These fmdings indicate that the recombinant blot test is very
sensitive for the detection of anti-gp4l. This is an important
advantage since many specimens that are positive in a screening test
are ? positive in conventional WB because no anti-gp41 can be
demonstrated.
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